Fox Chase Cancer Center

Legal name: The Institute For Cancer Research

Nonprofit profile at a glance

EIN
236296135
IRS 990 coverage
2009–2024
Official website data refreshed
Sep 2026
Forms available
Form 990 2024
Location
Philadelphia, PA, United States
Phone
888-369-2427
Rating
74
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Health

Official website

Reported finances

Revenue
$94,545,853
Expenses
$104,429,815
Assets
$191,981,593
Liabilities
$81,790,850

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

31 people listed

Executive titles in this filing

  • Dr Robert Uzzo (President & CEO)

Highest reported compensation

  • Michael Young (Director): $2,136,271 total reported compensation
  • Dr Robert Uzzo (President & CEO): $1,582,504 total reported compensation
  • Amy Goldberg (Director): $1,215,526 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care. Our physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet status for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. Underlying all this exceptional skill is unparalleled compassion. Our mission-driven culture leads each of us—regardless of position, both long-timers and newcomers, those involved directly in patient care and those who support the many other operations of our institution—to claim a personal sense of ownership in prevailing o.

What it reported doing in 2024

The Institute for Cancer Research and its Research programs are renowned world-wide for their work in understanding both normal and abnormal cell growth. Scientists are involved in studies of genes that cause or inhibit cancer growth, virology, immunology, chemical carcinogens, cell growth and interaction and gene expression. In recent years, research has increasingly emphasized molecular oncology and genetics, areas which bridge advancing knowledge from the laboratory with new clinical approaches.

Operating model

Revenue model
Mixed. Its operating money came from several sources; no one source provided a clear majority.
Distribution model
Direct operator. The filing allocates 99% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence and fundraising costs are high for each dollar raised.

Rating breakdown

  • Financial Efficiency: 71
  • Transparency & Controls: 71
  • Accountability: 88
  • Sustainability: 29
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 76.3%; rating input score 76
  • Program expense ratio: 69.2%; rating input score 69
  • Fundraising efficiency: $13.63 raised per $1 spent on fundraising; rating input score 49; 49th percentile among comparable filings

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 68th percentile among comparable filings
  • Pay-setting controls: 0 of 6 controls in place; rating input score 0
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Missing
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 100%; rating input score 100; 77th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 86.7%; rating input score 87; 33rd percentile among comparable filings
  • Governance controls: 8 of 9 controls in place; rating input score 89
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Fail
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: -10.5%; rating input score 8; 8th percentile among comparable filings
  • Total-asset coverage ratio: 1.84; rating input score 60; 60th percentile among comparable filings
  • Liabilities to assets ratio: 0.43; rating input score 42; 42nd percentile among comparable filings
  • Officer compensation ratio: 4.6%; rating input score 20; 20th percentile among comparable filings

Growth

  • Program expense growth: 2.8% per year; rating input score 100; 20th percentile among comparable filings
  • Revenue growth: 6.9% per year; rating input score 100; 60th percentile among comparable filings
  • Asset growth: 3.9% per year; rating input score 100; 27th percentile among comparable filings

Details

  • What they do: 1 programs and campaigns described on the official site · 1 operating location identified
  • Where the money goes: 76.3% of revenue deployed · 69.2% of spending went to programs
  • Governance: 13 of 15 board members independent · 8 of 9 filing controls reported
  • Programs: 2 filed program accomplishments · $72.3M in reported program spending
  • Leadership: top reported pay $2.1M · 31 people listed · 0 of 6 pay-setting controls reported
  • Highest-paid contractors: 5 contractors listed · $12M reported
  • Consistency: 31 of 31 current checks pass
  • Schedules: 8 filed schedules · includes major donors, grants, and executive pay
  • Filing history: 15 filing years from 2009 to 2024
  • Contacts: How to reach this organization
  • Money network: 10 filed money-flow records
  • Related organizations: 19 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Transparency & Controls: Pay-setting controls scored 0/100.
  • Moderate — Financial Efficiency: Fundraising efficiency scored 49/100.
  • High — Sustainability: Operating margin scored 8/100.
  • Review — Accountability: Governance controls: CEO compensation review process not reported.
  • High — Sustainability: Officer compensation ratio scored 20/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 42/100.